Source: Annual Congress 2010 - Pulmonary hypertension updates
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Frost, D. Badesch, D. Miller, R. Benza, M. McGoon (Houston, Denver, San Francisco, Pittsburgh, Rochester, United States Of America). 2-year outcomes in newly and previously diagnosed patients with pulmonary arterial hypertension enrolled in REVEAL. Eur Respir J 2010; 36: Suppl. 54, 1917

Member's Comments

No comment yet.

Related content which might interest you: Long–term follow-up of patients on sildenafil from Croatian pulmonary hypertension registry Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 French pulmonary arterial hypertension registry in children: 2-year follow-up data Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Results of a 12-week outpatient cardiovascular rehabilitation in patients with idiopathic pulmonary arterial hypertension (iPAH) Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Clinical features in patients diagnosed of pulmonary hypertension: a retrospective study of 15 cases Source: Eur Respir J 2005; 26: Suppl. 49, 520s Year: 2005 Baseline profile of patients initiating sitaxentan for pulmonary arterial hypertension (PAH): preliminary results from thelin outcomes for patients surveillance (TOPS) Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Impact of functional class change on survival in patients with pulmonary arterial hypertension in the REVEAL registry Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 549-555 Year: 2010 Longer-term survival in paediatric patients with idiopathic or familial pulmonary arterial hypertension treated with bosentan Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003 Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study Source: Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017 Year: 2017 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Long-term outcomes of percutaneous coronary intervention in patients with chronic obstructive pulmonary disease: a 13-year nationwide cohort study Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017 Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 Characteristics and outcome of patients with pre-capillary pulmonary hypertension who were drained for tamponade: A monocentric study Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Depressive symptoms among patients with chronic obstructive pulmonary disease before and after smoking cessation – a Danish nationwide cohort study of 21 184 patients Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Initial combination of macitentan and tadalafil in newly diagnosed patients with pulmonary arterial hypertension (PAH): results from the OPTIMA study Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020